Global InformationEKF Diagnostics information
 | |
| Company type | Public company |
|---|---|
Traded as | LSE: EKF EKF Diagnostics Holdings plc |
| Industry | Health Care Biotechnology |
| Predecessor | EKF Diagnostics GmbH |
| Founded | Barleben, Germany (1990) |
| Founder | Berthold Walter |
| Headquarters | Cardiff, United Kingdom |
Area served | Worldwide |
Key people | Christopher Mills (Non-Executive Chairman) Mike Salter (Chief Executive Officer) Marc Davies (Chief Financial Officer) |
| Revenue |  £21.658 million (2011) |
| Total assets | £58.733 million (2011) |
| Total equity | £37.427 million (2011) |
Number of employees | 295 (2011) |
| Subsidiaries | Argutus Medical Quotient Diagnostics Stanbio Laboratory |
| Website | www.ekfdiagnostics.com |
EKF Diagnostics (Entwicklung, Konstruktion und Fertigung) is a publicly listed Healthcare company founded 1990 in Barleben, Germany and currently headquartered in Cardiff, Wales, UK.
EKF Diagnostics specialises in the development, manufacture and distribution of point of care analysers for hemoglobin, HbA1c, glucose, lactate as well as a range of clinical chemistry products and biomarker-based ELISA & rapid tests, a result of EKF Diagnostics' acquisition of Stanbio and Argutus Medical. EKF Diagnostics has nine sites in six countries and employs 295 people as of 31 December 2011.